TY - JOUR
T1 - Mitochondrial function-associated genes underlie cortical atrophy in prodromal synucleinopathies
AU - Rahayel, Shady
AU - Tremblay, Christina
AU - Vo, Andrew
AU - Misic, Bratislav
AU - Lehéricy, Stéphane
AU - Arnulf, Isabelle
AU - Vidailhet, Marie
AU - Corvol, Jean Christophe
AU - ICEBERG Study Group
AU - Mangone, Graziella
AU - Sambin, Sara
AU - Ihle, Jonas
AU - Weill, Caroline
AU - Grabli, David
AU - Cormier-Dequaire, Florence
AU - Mariani, Louise Laure
AU - Degos, Bertrand
AU - Levy, Richard
AU - Pineau, Fanny
AU - Socha, Julie
AU - Benchetrit, Eve
AU - Czernecki, Virginie
AU - Glachant, Marie Alexandrine
AU - Rivaud-Pechoux, Sophie
AU - Hainque, Elodie
AU - Semenescu, Smaranda Leu
AU - Dodet, Pauline
AU - Bekadar, Samir
AU - Brice, Alexis
AU - Lesage, Suzanne
AU - Mochel, Fanny
AU - Ichou, Farid
AU - Perlbarg, Vincent
AU - Colsch, Benoit
AU - Tenenhaus, Arthur
AU - Gaurav, Rahul
AU - Pyatigorskaya, Nadya
AU - Yahia-Cherif, Lydia
AU - Valabrègue, Romain
AU - Galléa, Cécile
AU - Habert, Marie Odile
AU - Petrovska, Dijana
AU - Jeancolas, Laetitia
AU - Brochard, Vanessa
AU - Chalançon, Alizé
AU - Dongmo-Kenfack, Carole
AU - Laganot, Christelle
AU - Maheo, Valentine
AU - Gagnon, Jean François
AU - Postuma, Ronald B.
AU - Montplaisir, Jacques
AU - Lewis, Simon
AU - Matar, Elie
AU - Ehgoetz Martens, Kaylena
AU - Borghammer, Per
AU - Knudsen, Karoline
AU - Hansen, Allan K.
AU - Monchi, Oury
AU - Gan-Or, Ziv
AU - Dagher, Alain
AU - Alzheimer's Disease Neuroimaging Initiative
N1 - Copyright the Author(s) 2023. Version archived for private and non-commercial use with the permission of the author/s and according to publisher conditions. For further rights please contact the publisher.
PY - 2023/8/1
Y1 - 2023/8/1
N2 - Isolated rapid eye movement sleep behaviour disorder (iRBD) is a sleep disorder characterized by the loss of rapid eye movement sleep muscle atonia and the appearance of abnormal movements and vocalizations during rapid eye movement sleep. It is a strong marker of incipient synucleinopathy such as dementia with Lewy bodies and Parkinson's disease. Patients with iRBD already show brain changes that are reminiscent of manifest synucleinopathies including brain atrophy. However, the mechanisms underlying the development of this atrophy remain poorly understood. In this study, we performed cutting-edge imaging transcriptomics and comprehensive spatial mapping analyses in a multicentric cohort of 171 polysomnography-confirmed iRBD patients [67.7 ± 6.6 (49-87) years; 83% men] and 238 healthy controls [66.6 ± 7.9 (41-88) years; 77% men] with T1-weighted MRI to investigate the gene expression and connectivity patterns associated with changes in cortical thickness and surface area in iRBD. Partial least squares regression was performed to identify the gene expression patterns underlying cortical changes in iRBD. Gene set enrichment analysis and virtual histology were then done to assess the biological processes, cellular components, human disease gene terms, and cell types enriched in these gene expression patterns. We then used structural and functional neighbourhood analyses to assess whether the atrophy patterns in iRBD were constrained by the brain's structural and functional connectome. Moreover, we used comprehensive spatial mapping analyses to assess the specific neurotransmitter systems, functional networks, cytoarchitectonic classes, and cognitive brain systems associated with cortical changes in iRBD. All comparisons were tested against null models that preserved spatial autocorrelation between brain regions and compared to Alzheimer's disease to assess the specificity of findings to synucleinopathies. We found that genes involved in mitochondrial function and macroautophagy were the strongest contributors to the cortical thinning occurring in iRBD. Moreover, we demonstrated that cortical thinning was constrained by the brain's structural and functional connectome and that it mapped onto specific networks involved in motor and planning functions. In contrast with cortical thickness, changes in cortical surface area were related to distinct genes, namely genes involved in the inflammatory response, and to different spatial mapping patterns. The gene expression and connectivity patterns associated with iRBD were all distinct from those observed in Alzheimer's disease. In summary, this study demonstrates that the development of brain atrophy in synucleinopathies is constrained by specific genes and networks.
AB - Isolated rapid eye movement sleep behaviour disorder (iRBD) is a sleep disorder characterized by the loss of rapid eye movement sleep muscle atonia and the appearance of abnormal movements and vocalizations during rapid eye movement sleep. It is a strong marker of incipient synucleinopathy such as dementia with Lewy bodies and Parkinson's disease. Patients with iRBD already show brain changes that are reminiscent of manifest synucleinopathies including brain atrophy. However, the mechanisms underlying the development of this atrophy remain poorly understood. In this study, we performed cutting-edge imaging transcriptomics and comprehensive spatial mapping analyses in a multicentric cohort of 171 polysomnography-confirmed iRBD patients [67.7 ± 6.6 (49-87) years; 83% men] and 238 healthy controls [66.6 ± 7.9 (41-88) years; 77% men] with T1-weighted MRI to investigate the gene expression and connectivity patterns associated with changes in cortical thickness and surface area in iRBD. Partial least squares regression was performed to identify the gene expression patterns underlying cortical changes in iRBD. Gene set enrichment analysis and virtual histology were then done to assess the biological processes, cellular components, human disease gene terms, and cell types enriched in these gene expression patterns. We then used structural and functional neighbourhood analyses to assess whether the atrophy patterns in iRBD were constrained by the brain's structural and functional connectome. Moreover, we used comprehensive spatial mapping analyses to assess the specific neurotransmitter systems, functional networks, cytoarchitectonic classes, and cognitive brain systems associated with cortical changes in iRBD. All comparisons were tested against null models that preserved spatial autocorrelation between brain regions and compared to Alzheimer's disease to assess the specificity of findings to synucleinopathies. We found that genes involved in mitochondrial function and macroautophagy were the strongest contributors to the cortical thinning occurring in iRBD. Moreover, we demonstrated that cortical thinning was constrained by the brain's structural and functional connectome and that it mapped onto specific networks involved in motor and planning functions. In contrast with cortical thickness, changes in cortical surface area were related to distinct genes, namely genes involved in the inflammatory response, and to different spatial mapping patterns. The gene expression and connectivity patterns associated with iRBD were all distinct from those observed in Alzheimer's disease. In summary, this study demonstrates that the development of brain atrophy in synucleinopathies is constrained by specific genes and networks.
KW - dementia with Lewy bodies
KW - MRI
KW - network analysis
KW - Parkinson's disease
KW - REM sleep behaviour disorder
KW - transcriptomics
UR - http://www.scopus.com/inward/record.url?scp=85162141758&partnerID=8YFLogxK
U2 - 10.1093/brain/awad044
DO - 10.1093/brain/awad044
M3 - Article
C2 - 36826230
AN - SCOPUS:85162141758
SN - 0006-8950
VL - 146
SP - 3301
EP - 3318
JO - Brain
JF - Brain
IS - 8
ER -